Andrea Siebenhofer1, Klaus Jeitler, Karl Horvath, Wolfgang Habacher, Louise Schmidt, Thomas Semlitsch. 1. Institute of General Practice, J. W. Goethe University, Frankfurt/Main, EBM Review Center, Medical University of Graz, Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Institute of Biomedicine and Health Sciences (HEALTH), JOANNEUM RESEARCH Forschungsgesellschaft mbh, Graz.
Abstract
BACKGROUND: Properly dosed oral anticoagulation effectively prevents thromboembolic events. It is unclear whether adult patients with an indication for long-term oral anticoagulation can benefit from self-management in terms of patient-oriented endpoints and improved coagulation values. METHOD: We selectively searched the Medline database for high-quality systematic reviews based on randomized controlled trials of self-measurement or self-management of oral anticoagulation, compared to standard treatment. RESULTS: We identified eight review articles based on overlapping sets of ran - domized clinical trials. In all of these systematic reviews, patients who performed self-measurement or self-management had a 40% to 50% lower rate of thromboembolic events; in six of them, the mortality was also significantly lower, by 30% to 50%. Subgroup analysis revealed that these effects were present exclusively in patients who performed self-management, and not in those who only performed self-measurement. None of the review articles revealed any difference in the frequency of severe hemorrhagic events. Quality of life and patient satisfaction were rated in five reviews, which, however, used different instruments, with the result that no clear conclusions could be drawn. All of the review articles documented an improvement in coagulation values, but information on statistical significance was mostly lacking. CONCLUSION: Adults with an indication for long-term oral anticoagulation benefit from self-management, as compared to standard treatment with management of dosing by a physician. A limitation of this study is that the multiple review articles on which it is based were largely analyses of the same group of clinical trials.
BACKGROUND: Properly dosed oral anticoagulation effectively prevents thromboembolic events. It is unclear whether adult patients with an indication for long-term oral anticoagulation can benefit from self-management in terms of patient-oriented endpoints and improved coagulation values. METHOD: We selectively searched the Medline database for high-quality systematic reviews based on randomized controlled trials of self-measurement or self-management of oral anticoagulation, compared to standard treatment. RESULTS: We identified eight review articles based on overlapping sets of ran - domized clinical trials. In all of these systematic reviews, patients who performed self-measurement or self-management had a 40% to 50% lower rate of thromboembolic events; in six of them, the mortality was also significantly lower, by 30% to 50%. Subgroup analysis revealed that these effects were present exclusively in patients who performed self-management, and not in those who only performed self-measurement. None of the review articles revealed any difference in the frequency of severe hemorrhagic events. Quality of life and patient satisfaction were rated in five reviews, which, however, used different instruments, with the result that no clear conclusions could be drawn. All of the review articles documented an improvement in coagulation values, but information on statistical significance was mostly lacking. CONCLUSION: Adults with an indication for long-term oral anticoagulation benefit from self-management, as compared to standard treatment with management of dosing by a physician. A limitation of this study is that the multiple review articles on which it is based were largely analyses of the same group of clinical trials.
Authors: Neree Claes; Frank Buntinx; Johan Vijgen; Jef Arnout; Jos Vermylen; Steffen Fieuws; Herman Van Loon Journal: Eur Heart J Date: 2005-05-25 Impact factor: 29.983
Authors: A D Oxman; G H Guyatt; J Singer; C H Goldsmith; B G Hutchison; R A Milner; D L Streiner Journal: J Clin Epidemiol Date: 1991 Impact factor: 6.437
Authors: A P A Gadisseur; W G M Breukink-Engbers; F J M van der Meer; A M H van den Besselaar; A Sturk; F R Rosendaal Journal: Arch Intern Med Date: 2003-11-24
Authors: Andrea Siebenhofer; Lisa R Ulrich; Karola Mergenthal; Ina Roehl; Sandra Rauck; Andrea Berghold; Sebastian Harder; Ferdinand M Gerlach; Juliana J Petersen Journal: Implement Sci Date: 2012-08-28 Impact factor: 7.327
Authors: Stefan Viktor Vormfelde; Manar Abu Abed; Thanh Duc Hua; Simon Schneider; Tim Friede; Jean-François Chenot Journal: Dtsch Arztebl Int Date: 2014-09-12 Impact factor: 5.594
Authors: Andrea Siebenhofer; Lisa-Rebekka Ulrich; Karola Mergenthal; Andrea Berghold; Gudrun Pregartner; Birgit Kemperdick; Sylvia Schulz-Rothe; Sandra Rauck; Sebastian Harder; Ferdinand Michael Gerlach; Juliana Johanna Petersen Journal: PLoS One Date: 2019-01-09 Impact factor: 3.240
Authors: Florian J Raimann; Marie-Louise Lindner; Christoph Martin; Lukas Jennewein; Thomas Lustenberger; Florian Piekarski; Kai Zacharowski; Christian F Weber Journal: Pract Lab Med Date: 2021-05-23
Authors: Abdullah U Althemery; Abdullah A Alfaifi; Abdulrahman Alturaiki; Maha A L Ammari; Khizra Sultana; Leanne Lai Journal: Ann Thorac Med Date: 2020-04-03 Impact factor: 2.219